APO Research
Talk to an analyst

APO RESEARCH · REPORT

Streptococcus Pneumoniae Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchStreptococcus Pneumoniae Polysaccharide Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Streptococcus Pneumoniae Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine include Yuxi Watson Biotechnology Co., Ltd, Merck & Co.,Inc, Pfizer Inc, Chengdu Institute of Biological Products Co., Ltd, Beijing Minhai Biotechnology Co., Ltd, Beijing Kexing Biological Products Co., Ltd, Serum Institute of India Pvt. Ltd, Sanofi Pasteur and Glaxosmithkline Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Streptococcus Pneumoniae Polysaccharide Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Streptococcus Pneumoniae Polysaccharide Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Streptococcus Pneumoniae Polysaccharide Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Streptococcus Pneumoniae Polysaccharide Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Company

Yuxi Watson Biotechnology Co., Ltd

Merck & Co.,Inc

Pfizer Inc

Chengdu Institute of Biological Products Co., Ltd

Beijing Minhai Biotechnology Co., Ltd

Beijing Kexing Biological Products Co., Ltd

Serum Institute of India Pvt. Ltd

Sanofi Pasteur

Glaxosmithkline Plc

China National Biotec Group

Astellas Pharma Inc

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-Filled Syringe

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Application

Hospital

Clinic

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Streptococcus Pneumoniae Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Streptococcus Pneumoniae Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Streptococcus Pneumoniae Polysaccharide Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Streptococcus Pneumoniae Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Streptococcus Pneumoniae Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends Table 2. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers Table 3. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges Table 4. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints Table 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Manufacturers Table 9. Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers, Product Type & Application Table 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Dose Vial Table 17. Major Manufacturers of Pre-Filled Syringe Table 18. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 62. Yuxi Watson Biotechnology Co., Ltd Company Information Table 63. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 64. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 66. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 67. Merck & Co.,Inc Company Information Table 68. Merck & Co.,Inc Business Overview Table 69. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 71. Merck & Co.,Inc Recent Development Table 72. Pfizer Inc Company Information Table 73. Pfizer Inc Business Overview Table 74. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 76. Pfizer Inc Recent Development Table 77. Chengdu Institute of Biological Products Co., Ltd Company Information Table 78. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 79. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 81. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 82. Beijing Minhai Biotechnology Co., Ltd Company Information Table 83. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 84. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 86. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 87. Beijing Kexing Biological Products Co., Ltd Company Information Table 88. Beijing Kexing Biological Products Co., Ltd Business Overview Table 89. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 91. Beijing Kexing Biological Products Co., Ltd Recent Development Table 92. Serum Institute of India Pvt. Ltd Company Information Table 93. Serum Institute of India Pvt. Ltd Business Overview Table 94. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 96. Serum Institute of India Pvt. Ltd Recent Development Table 97. Sanofi Pasteur Company Information Table 98. Sanofi Pasteur Business Overview Table 99. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 101. Sanofi Pasteur Recent Development Table 102. Glaxosmithkline Plc Company Information Table 103. Glaxosmithkline Plc Business Overview Table 104. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 106. Glaxosmithkline Plc Recent Development Table 107. China National Biotec Group Company Information Table 108. China National Biotec Group Business Overview Table 109. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 111. China National Biotec Group Recent Development Table 112. Astellas Pharma Inc Company Information Table 113. Astellas Pharma Inc Business Overview Table 114. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 116. Astellas Pharma Inc Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Streptococcus Pneumoniae Polysaccharide Vaccine Distributors List Table 120. Streptococcus Pneumoniae Polysaccharide Vaccine Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Streptococcus Pneumoniae Polysaccharide Vaccine Product Image Figure 2. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Streptococcus Pneumoniae Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Dose Vial Image Figure 9. Pre-Filled Syringe Image Figure 10. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Streptococcus Pneumoniae Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-Filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuxi Watson Biotechnology Co., Ltd
  • Merck & Co.,Inc
  • Pfizer Inc
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Kexing Biological Products Co., Ltd
  • Serum Institute of India Pvt. Ltd
  • Sanofi Pasteur
  • Glaxosmithkline Plc
  • China National Biotec Group
  • Astellas Pharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Dynamics
  1. 2.1 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends
  2. 2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers
  3. 2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints
3 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Manufacturers
  1. 3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Streptococcus Pneumoniae Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Streptococcus Pneumoniae Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Type
  1. 4.1 Streptococcus Pneumoniae Polysaccharide Vaccine Type Introduction
  2. 4.1.1 Single Dose Vial
  3. 4.1.2 Pre-Filled Syringe
  4. 4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type
  5. 4.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type
  9. 4.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
5 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Application
  1. 5.1 Streptococcus Pneumoniae Polysaccharide Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application
  5. 5.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application
  9. 5.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
6 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region
  1. 6.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region
  1. 7.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region
  2. 7.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuxi Watson Biotechnology Co., Ltd
  2. 8.1.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  3. 8.1.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  4. 8.1.3 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  6. 8.1.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
  7. 8.2 Merck & Co.,Inc
  8. 8.2.1 Merck & Co.,Inc Company Information
  9. 8.2.2 Merck & Co.,Inc Business Overview
  10. 8.2.3 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  12. 8.2.5 Merck & Co.,Inc Recent Developments
  13. 8.3 Pfizer Inc
  14. 8.3.1 Pfizer Inc Company Information
  15. 8.3.2 Pfizer Inc Business Overview
  16. 8.3.3 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  18. 8.3.5 Pfizer Inc Recent Developments
  19. 8.4 Chengdu Institute of Biological Products Co., Ltd
  20. 8.4.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  21. 8.4.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  22. 8.4.3 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  24. 8.4.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  25. 8.5 Beijing Minhai Biotechnology Co., Ltd
  26. 8.5.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  27. 8.5.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  28. 8.5.3 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  30. 8.5.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  31. 8.6 Beijing Kexing Biological Products Co., Ltd
  32. 8.6.1 Beijing Kexing Biological Products Co., Ltd Company Information
  33. 8.6.2 Beijing Kexing Biological Products Co., Ltd Business Overview
  34. 8.6.3 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  36. 8.6.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
  37. 8.7 Serum Institute of India Pvt. Ltd
  38. 8.7.1 Serum Institute of India Pvt. Ltd Company Information
  39. 8.7.2 Serum Institute of India Pvt. Ltd Business Overview
  40. 8.7.3 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  42. 8.7.5 Serum Institute of India Pvt. Ltd Recent Developments
  43. 8.8 Sanofi Pasteur
  44. 8.8.1 Sanofi Pasteur Company Information
  45. 8.8.2 Sanofi Pasteur Business Overview
  46. 8.8.3 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  48. 8.8.5 Sanofi Pasteur Recent Developments
  49. 8.9 Glaxosmithkline Plc
  50. 8.9.1 Glaxosmithkline Plc Company Information
  51. 8.9.2 Glaxosmithkline Plc Business Overview
  52. 8.9.3 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  54. 8.9.5 Glaxosmithkline Plc Recent Developments
  55. 8.10 China National Biotec Group
  56. 8.10.1 China National Biotec Group Company Information
  57. 8.10.2 China National Biotec Group Business Overview
  58. 8.10.3 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  60. 8.10.5 China National Biotec Group Recent Developments
  61. 8.11 Astellas Pharma Inc
  62. 8.11.1 Astellas Pharma Inc Company Information
  63. 8.11.2 Astellas Pharma Inc Business Overview
  64. 8.11.3 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  66. 8.11.5 Astellas Pharma Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Analysis
  2. 9.1.1 Streptococcus Pneumoniae Polysaccharide Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process
  6. 9.2 Streptococcus Pneumoniae Polysaccharide Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Distributors
  9. 9.2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst